BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34731482)

  • 1. Machine Learning for In Silico ADMET Prediction.
    Jia L; Gao H
    Methods Mol Biol; 2022; 2390():447-460. PubMed ID: 34731482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Recent Appraisal of Artificial Intelligence and In Silico ADMET Prediction in the Early Stages of Drug Discovery.
    Kumar A; Kini SG; Rathi E
    Mini Rev Med Chem; 2021; 21(18):2788-2800. PubMed ID: 33797376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine Learning Applied to the Modeling of Pharmacological and ADMET Endpoints.
    Göller AH; Kuhnke L; Ter Laak A; Meier K; Hillisch A
    Methods Mol Biol; 2022; 2390():61-101. PubMed ID: 34731464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayer's in silico ADMET platform: a journey of machine learning over the past two decades.
    Göller AH; Kuhnke L; Montanari F; Bonin A; Schneckener S; Ter Laak A; Wichard J; Lobell M; Hillisch A
    Drug Discov Today; 2020 Sep; 25(9):1702-1709. PubMed ID: 32652309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADMETboost: a web server for accurate ADMET prediction.
    Tian H; Ketkar R; Tao P
    J Mol Model; 2022 Dec; 28(12):408. PubMed ID: 36454321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling ADMET.
    Ghosh J; Lawless MS; Waldman M; Gombar V; Fraczkiewicz R
    Methods Mol Biol; 2016; 1425():63-83. PubMed ID: 27311462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling Physico-Chemical ADMET Endpoints with Multitask Graph Convolutional Networks.
    Montanari F; Kuhnke L; Ter Laak A; Clevert DA
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31877719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules.
    Khan MT; Sylte I
    Curr Drug Discov Technol; 2007 Oct; 4(3):141-9. PubMed ID: 17985997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of in silico drug-likeness predictions in pharmaceutical research.
    Tian S; Wang J; Li Y; Li D; Xu L; Hou T
    Adv Drug Deliv Rev; 2015 Jun; 86():2-10. PubMed ID: 25666163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward in silico structure-based ADMET prediction in drug discovery.
    Moroy G; Martiny VY; Vayer P; Villoutreix BO; Miteva MA
    Drug Discov Today; 2012 Jan; 17(1-2):44-55. PubMed ID: 22056716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles.
    Sanders JM; Beshore DC; Culberson JC; Fells JI; Imbriglio JE; Gunaydin H; Haidle AM; Labroli M; Mattioni BE; Sciammetta N; Shipe WD; Sheridan RP; Suen LM; Verras A; Walji A; Joshi EM; Bueters T
    J Med Chem; 2017 Aug; 60(16):6771-6780. PubMed ID: 28418656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADMET Evaluation in Drug Discovery. 18. Reliable Prediction of Chemical-Induced Urinary Tract Toxicity by Boosting Machine Learning Approaches.
    Lei T; Sun H; Kang Y; Zhu F; Liu H; Zhou W; Wang Z; Li D; Li Y; Hou T
    Mol Pharm; 2017 Nov; 14(11):3935-3953. PubMed ID: 29037046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools.
    Tao L; Zhang P; Qin C; Chen SY; Zhang C; Chen Z; Zhu F; Yang SY; Wei YQ; Chen YZ
    Adv Drug Deliv Rev; 2015 Jun; 86():83-100. PubMed ID: 26037068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADMET Profiling in Drug Discovery and Development: Perspectives of In Silico, In Vitro and Integrated Approaches.
    Daoud NE; Borah P; Deb PK; Venugopala KN; Hourani W; Alzweiri M; Bardaweel SK; Tiwari V
    Curr Drug Metab; 2021; 22(7):503-522. PubMed ID: 34225615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying machine learning techniques for ADME-Tox prediction: a review.
    Maltarollo VG; Gertrudes JC; Oliveira PR; Honorio KM
    Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):259-71. PubMed ID: 25440524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico machine learning methods in drug development.
    Dobchev DA; Pillai GG; Karelson M
    Curr Top Med Chem; 2014; 14(16):1913-22. PubMed ID: 25262800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADMET in silico modelling: towards prediction paradise?
    van de Waterbeemd H; Gifford E
    Nat Rev Drug Discov; 2003 Mar; 2(3):192-204. PubMed ID: 12612645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine learning models for classification tasks related to drug safety.
    Rácz A; Bajusz D; Miranda-Quintana RA; Héberger K
    Mol Divers; 2021 Aug; 25(3):1409-1424. PubMed ID: 34110577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep Neural Networks for QSAR.
    Xu Y
    Methods Mol Biol; 2022; 2390():233-260. PubMed ID: 34731472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico ADMET prediction: recent advances, current challenges and future trends.
    Cheng F; Li W; Liu G; Tang Y
    Curr Top Med Chem; 2013; 13(11):1273-89. PubMed ID: 23675935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.